Effects of natural products on cisplatin ototoxicity and chemotherapeutic efficacy

INTRODUCTION: Cisplatin is a very effective chemotherapeutic agent against a variety of solid tumors. Unfortunately, cisplatin causes permanent sensorineural hearing loss in at least two-thirds of patients treated. There are no FDA approved drugs to prevent this serious side effect.

AREAS COVERED: This paper reviews various natural products that ameliorate cisplatin ototoxicity. These compounds are strong antioxidants and anti-inflammatory agents. This review includes mostly preclinical studies but also discusses a few small clinical trials with natural products to minimize hearing loss from cisplatin chemotherapy in patients. The interactions of natural products with cisplatin in tumor-bearing animal models are highlighted. A number of natural products did not interfere with cisplatin anti-tumor efficacy and some agents actually potentiated cisplatin anti-tumor activity.

EXPERT OPINION: There are a number of natural products or their derivatives that show excellent protection against cisplatin ototoxicity in preclinical studies. There is a need to insure uniform standards for purity of drugs derived from natural sources and to ensure adequate pharmacokinetics and safety of these products. Natural products that protect against cisplatin ototoxicity and augment cisplatin's anti-tumor effects in multiple studies of tumor-bearing animals are most promising for advancement to clinical trials. The most promising natural products include honokiol, sulforaphane, and thymoquinone.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:19

Enthalten in:

Expert opinion on drug metabolism & toxicology - 19(2023), 9 vom: 20. Sept., Seite 635-652

Sprache:

Englisch

Beteiligte Personen:

Rybak, Leonard P [VerfasserIn]
Alberts, Ian [VerfasserIn]
Patel, Shree [VerfasserIn]
Al Aameri, Raheem F H [VerfasserIn]
Ramkumar, Vickram [VerfasserIn]

Links:

Volltext

Themen:

Anti-inflammatory agents
Antioxidants
Chemotherapeutic efficacy
Cisplatin
Hearing loss
Journal Article
Otoprotection
Ototoxicity
Review

Anmerkungen:

Date Revised 12.10.2023

published: Print-Electronic

Citation Status Publisher

doi:

10.1080/17425255.2023.2260737

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM362253552